On October 10th, 2024, the World Pharmaceutical Raw Materials Exhibition (2024 CPHI Europe) was successfully concluded at the Milan Convention Center in Italy. As the world's largest pharmaceutical raw materials exhibition, 2024 CPHI Europe brought together more than 2,400 exhibitors and attracted 62,000 pharmaceutical business owners, raw material suppliers, scientific research institutions and industry experts from more than 166 countries and regions. HumanwellCaps who has specialized in empty capsules for nearly 20 years, as the future leader in the segment of pharmaceutical excipients, also was invited to participate in this event, showing its excellent scientific research strength in empty capsules and forward-looking international layout to the world.

Since its establishment in 2005, HumanwellCaps has always been committed to the development of empty capsules. After nearly twenty years of lean and deep cultivation, HumanwellCaps has accumulated profound competitive advantages in gelatin capsules, vegetable capsules, special capsules and other capsules series. HumanwellCaps has passed cGMP, has gained HALAL, KOSHER, ISO9001, IS022000 and other international certifications, has passed the EU registration, and is applying for US. DMF. HumanwellCaps is moving steadily on the road of internationalization.

During the exhibition, HumanwellCaps's booth(Booth No: 6C80) is full of visitors. HumanwellCaps's gelatin capsules, HPMC capsules, Pullulan capsules, enteric-coated capsules and other featured empty capsules attracted many new and old customers to stop to watch and consult. HumanwellCaps team warmly received partners and industry elites from all over the world. Through in-depth face-to-face communication, HumanwellCaps not only deepened the cooperative relationship with existing customers, but also successfully attracted the interest of more potential customers, and significantly improved the brand recognition and trust. This exhibition has also strengthened the mutual trust and cooperation with core customers, laying a solid foundation for the in-depth strategic cooperation between the two sides in the future.

In the future, HumanwellCaps will continue to focus on innovation and development, continue to deepen research and development on empty capsules and international strategic layout, and constantly consolidate global operational capabilities, committed to becoming a leading enterprise in the field of global pharmaceutical excipients, and make due contributions to the global pharmaceutical excipients industry.

Note: HumanwellCaps is heading for 2024 SupplySide West in Las Vegas on Oct 30th-31st, 2024. 
We will wait for your visiting on the HumanwellCaps booth (Booth No: 4155).
Exhibition Name: 2024 SupplySide West
Date: Oct 30th-31st, 2024
Booth No: 4155
Address: Mandalay Bay Hotel, Las Vegas, USA

About HumanwellCaps
Hubei Humanwell Pharmaceutical Excipients Co., Ltd.is a high-tech branch of Humanwell Healthcare Group, specializing in the production of capsules, and with over 20 years of capsules production experience. It is with planned total annual production capacity of 40 billions of empty capsules, currently has 16 imported automatic capsule production lines, and with an annual production capacity of 15 billions of capsules.